partial-thickness rotator cuff tears
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Primary, traumatic, or non-traumatic PTRCTs (T-PTRCTs or/and NT- PTRCTs) located in supraspinatus measuring not more than 6 mm according to Ellman's Classification; Symptomatic PTRCTs patients within 6 months of initial diagnosis.;Inclusion criteria: Primary, traumatic, or non-traumatic PTRCTs (T-PTRCTs or/and NT- PTRCTs) located in supraspinatus measuring not more than 6 mm according to Ellman's Classification; Symptomatic PTRCTs patients within 6 months of initial diagnosis.;Inclusion criteria: Primary, traumatic, or non-traumatic PTRCTs (T-PTRCTs or/and NT- PTRCTs) located in supraspinatus measuring not more than 6 mm according to Ellman's Classification; Symptomatic PTRCTs patients within 6 months of initial diagnosis.;Inclusion criteria: Primary, traumatic, or non-traumatic PTRCTs (T-PTRCTs or/and NT- PTRCTs) located in supraspinatus measuring not more than 6 mm according to Ellman's Classification; Symptomatic PTRCTs patients within 6 months of initial diagnosis.;Inclusion criteria: Primary, traumatic, or non-traumatic PTRCTs (T-PTRCTs or/and NT- PTRCTs) located in supraspinatus measuring not more than 6 mm according to Ellman's Classification; Symptomatic PTRCTs patients within 6 months of initial diagnosis.
Exclusion criteria
Exclusion criteria: Rotator cuff tears secondary to fracture; Prior surgical repair or revision arthroscopy; Prior platelet-rich plasma, sodium hyaluronate injection or other drug intervention; Previous history of pregnancy, mental sickness, cardio-cerebrovascular disease, shoulder pain induced by non-RCT; Active infection; Hemoglobin < 7.0 g/dl or platelets < 15,000/µL.;Exclusion criteria: Rotator cuff tears secondary to fracture; Prior surgical repair or revision arthroscopy; Prior platelet-rich plasma, sodium hyaluronate injection or other drug intervention; Previous history of pregnancy, mental sickness, cardio-cerebrovascular disease, shoulder pain induced by non-RCT; Active infection; Hemoglobin < 7.0 g/dl or platelets < 15,000/µL.;Exclusion criteria: Rotator cuff tears secondary to fracture; Prior surgical repair or revision arthroscopy; Prior platelet-rich plasma, sodium hyaluronate injection or other drug intervention; Previous history of pregnancy, mental sickness, cardio-cerebrovascular disease, shoulder pain induced by non-RCT; Active infection; Hemoglobin < 7.0 g/dl or platelets < 15,000/µL.;Exclusion criteria: Rotator cuff tears secondary to fracture; Prior surgical repair or revision arthroscopy; Prior platelet-rich plasma, sodium hyaluronate injection or other drug intervention; Previous history of pregnancy, mental sickness, cardio-cerebrovascular disease, shoulder pain induced by non-RCT; Active infection; Hemoglobin < 7.0 g/dl or platelets < 15,000/µL.;Exclusion criteria: Rotator cuff tears secondary to fracture; Prior surgical repair or revision arthroscopy; Prior platelet-rich plasma, sodium hyaluronate injection or other drug intervention; Previous history of pregnancy, mental sickness, cardio-cerebrovascular disease, shoulder pain induced by non-RCT; Active infection; Hemoglobin < 7.0 g/dl or platelets < 15,000/µL.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ASES score; | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS scroe;MRI; | — |
Countries
China
Contacts
Puai Hospital, Huazhong University of Science and Technology;Puai Hospital, Huazhong University of Science and Technology;Puai Hospital, Huazhong University of Science and Technology;Puai Hospital, Huazhong University of Science and Technology;Puai Hospital, Huazhong University of Science and Technology